Thermo Fisher Scientific Opens Manufacturing Site in Switzerland
October 01 2021 - 06:56AM
Dow Jones News
By Dave Sebastian
Thermo Fisher Scientific Inc. said it has opened a biologics
manufacturing site in Lengnau, Switzerland, as part of its
partnership with CSL Ltd.
The company on Friday said it would initially support the
manufacturing of CSL's Idelvion drug for patients with hemophilia B
after the construction for the 1.5 million-square-foot facility is
completed in 2022. It would then serve more biopharma customers
through the site.
Thermo Fisher said it would add about 200 employees in
connection with the site.
The company's biologics manufacturing network currently includes
Princeton, N.J.; St. Louis, Mo.; Groningen, Netherlands; Brisbane,
Australia; and Hangzhou, China.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
October 01, 2021 06:41 ET (10:41 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2023 to Mar 2024